US Patent 11358953 Functionalized peptides as antiviral agents
Patent 11358953 was granted and assigned to Enanta Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 9, 2021
Date of Patent
June 14, 2022
Patent Applicant
Patent Application Number
17522176
Patent Citations
•••
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11358953 Functionalized peptides as antiviral agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.